Explore Fiscal Year, Science and more!

Gilead Sciences, Inc. (GILD): Harvoni/Sovaldi Prescriptions Rise, UBS Weighs In On Q2 Sales

Gilead Sciences, Inc. (GILD): Harvoni/Sovaldi Prescriptions Rise, UBS Weighs In On Q2 Sales

Gilead Sciences, Inc. (GILD) Stock May See Surprise Upside: RBC

Gilead Sciences, Inc. (GILD) Stock May See Surprise Upside: RBC

Vivus (VVUS) Tumbles on Downgrade

Vivus (VVUS) Tumbles on Downgrade

Here’s Why Gilead Sciences, Inc. (GILD) Was Up Yesterday

Here’s Why Gilead Sciences, Inc. (GILD) Was Up Yesterday

Why Teva Pharmaceutical Industries (TEVA) Rejected Perrigo Company To Go After Mylan NV

Why Teva Pharmaceutical Industries (TEVA) Rejected Perrigo Company To Go After Mylan NV

GlaxoSmithKline plc (ADR) Wins FDA Panel Backing For Severe Asthma Drug

GlaxoSmithKline plc (ADR) Wins FDA Panel Backing For Severe Asthma Drug

A three-month formulation of Invega Sustenna, if approved, would be the first ever long-acting four-times-a-year treatment for schizophrenia in adults

A three-month formulation of Invega Sustenna, if approved, would be the first ever long-acting four-times-a-year treatment for schizophrenia in adults

GSK announced Thursday that it is no longer looking to divest its established products, which lost patent protection in North America and Europe. Bidness Etc investigates why and discusses other measures the company is taking to solve the financial problems it is facing

GSK announced Thursday that it is no longer looking to divest its established products, which lost patent protection in North America and Europe. Bidness Etc investigates why and discusses other measures the company is taking to solve the financial problems it is facing

After GlaxoSmithKline plc (ADR) (GSK), German Group Siemens AG (ADR) Being Probed By Chinese Regulators For Bribery: Reuters

After GlaxoSmithKline plc (ADR) (GSK), German Group Siemens AG (ADR) Being Probed By Chinese Regulators For Bribery: Reuters

Hillary Clinton will detail her plans to tackle high drug prices today. Here\'s how biotech stocks and the Street are reacting.

Hillary Clinton will detail her plans to tackle high drug prices today. Here\'s how biotech stocks and the Street are reacting.

Pinterest
Search